DRUGS MADE IN AMERICA ACQUISITION CORP. (DMAAR) Return on equity
DRUGS MADE IN AMERICA ACQUISITION CORP. (DMAAR) return on equity by fiscal year — reported net income divided by year-end shareholders’ equity.
No annual history for this metric yet
The company may have no SEC filings (ETF / non-US listing), or the concept is absent from its filings.
← Back to DMAARSource: SEC XBRL filings · For reference only · Not investment advice
More DMAAR financial trends
DMAAR RevenueDMAAR Net incomeDMAAR Net marginDMAAR Gross profitDMAAR Gross marginDMAAR Operating incomeDMAAR Operating marginDMAAR Operating cash flowDMAAR Free cash flowDMAAR Capital expendituresDMAAR Stock buybacksDMAAR Dividends paidDMAAR Total assetsDMAAR Total liabilitiesDMAAR Shareholders’ equityDMAAR overview →